Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Parmax Pharma Ltd - 540359 - Closure of Trading Window

 This is to inform you that pursuant to Company''s Code of Practices and Procedures and Code of Conduct to Regulate, Monitor and Report Trading in Securities and SEBI (Prohibition of Insider Trading) Regulations, 2015, ''Trading Window'' for dealing in securities of the Company for designated persons will remain closed with immediate effect till 48 hours after the declaration of financial results for the Quarter and financial year ended on 31st March, 2021. The date of announcement of the financial results for the quarter and financial year ended on 31st March, 2021 shall be announced in due course.
30-03-2021
Bigul

Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
02-03-2021
Bigul

Parmax Pharma Ltd - 540359 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Parmax Pharma Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
22-02-2021
Bigul

Parmax Pharma Ltd - 540359 - Withdrawal Of Our Application For Preferential Issue Of Shares To The Promoter, Non- Promoter And Public Entities.

 In continuation of our corporate announcement regarding E-Voting results and Scrutinizer report, We wish to inform you that due to non receipt of requisite majority from members for Special Resolutions contained in the postal ballot notice dated 16th January, 2021 the Company hereby withdraw the Proposed allotment of 13, 59,500 equity shares on preferential basis to the Promoter, Non Promoter and Public entities (proposed allottees).
20-02-2021
Bigul

Parmax Pharma Ltd - 540359 - Pursuant To Regulation 44(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations)'', We Hereby Enclose The Voting Results And Consolidated Scrutinizer''s Report Of Postal Ballot

 Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations)'', we hereby enclose the voting results and Consolidated Scrutinizer''s Report of Postal Ballot for resolution relating to: 1. Issue, offer and allot equity shares on preferential basis to promoters. 2. Issue, offer and allot equity shares on preferential basis to non-promoter entities. 3. Issue, offer and allot equity shares on preferential basis to public entities. The aforesaid resolution has not been passed through Postal Ballot and e-voting by Members with requisite majority.
20-02-2021
Bigul

Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the advertisement clipping of Extract of the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended 31st December, 2020 published in Financial Express (English & Gujarat Edition) dated 15th February, 2021
15-02-2021
Bigul

Parmax Pharma Ltd - 540359 - Outcome Of The Proceedings Of The Meeting Of The Board Of Directors Of The Company

 Outcome of the meeting of the Board of Directors
12-02-2021
Bigul

Parmax Pharma Ltd - 540359 - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2020.

 In continuation of our Corporate announcement dated 4th February, 2021 we hereby inform you that the Board of Directors of the Company has, at its meeting held today, inter-alia, considered and approved: i. Unaudited Financial Results for quarter and Nine months ended 31st December, 2020. The same has also been reviewed by the Audit Committee in its meeting held today. A copy of the Statement of Unaudited Financial Results for the quarter and nine months ended 31st December, 2020. We would like to submit that M/ s. B A Shah S R Mehta & Co., Statutory Auditors of Company have carried out limited review of Unaudited Financial Results for quarter and nine months ended 31st December, 2020 and Board has also taken on record their Limited Review Report on said Results. The meeting was commenced at 4.30 pm and was concluded at 5:45 pm. Since publications are closed on 14th February, 2021, hence our results can only be published on its next day i.e. 15th February 2021.
12-02-2021
Bigul

Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve we would like to inform you that the Meeting of the Board of Directors of Parmax Pharma Limited will be held on Friday, 12th February, 2021
04-02-2021
Bigul

Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Intimation of Resignation of Director of the Company.
04-02-2021
Next Page
Close

Let's Open Free Demat Account